Lundbeck
HLUN-B.CO
#2670
Rank
NZ$11.18 B
Marketcap
NZ$11.27
Share price
-1.12%
Change (1 day)
40.02%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2025 (TTM): NZ$1.03

According to Lundbeck's latest financial reports the company's current EPS (TTM) is NZ$1.04. an increase over its 2024 EPS that were of NZ$0.75.

EPS history for Lundbeck from 2004 to 2025

Annual EPS

Year EPS Change
2025NZ$0.8614.5%
2024NZ$0.7529.29%
2023NZ$0.5823.09%
2022NZ$0.4737.26%
2021NZ$0.34-84.61%
2020NZ$2.23-24.61%
2019NZ$2.96-42.06%
2018NZ$5.1040.7%
2017NZ$3.63146.26%
2016NZ$1.47-120.48%
2015NZ-$7.193231.32%
2014NZ-$0.22-115.78%
2013NZ$1.37-23.36%
2012NZ$1.78-48.01%
2011NZ$3.43-9.68%
2010NZ$3.8013.72%
2009NZ$3.3424.32%
2008NZ$2.69-6.05%
2007NZ$2.8681.77%
2006NZ$1.57-16.76%
2005NZ$1.89-17.58%
2004NZ$2.29